You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures

Authors

  • Joel M Kremer Division of Rheumatology, Department of Medicine, Albany Medical College, and The Center for Rheumatology (JMK), The New York State Department of Health (DAL) the Albany College of Pharmacy (RH), and The University of Glasgow (IBM), Albany, New York, USA PubMed articlesGoogle scholar articles
  • David A Lawrence Division of Rheumatology, Department of Medicine, Albany Medical College, and The Center for Rheumatology (JMK), The New York State Department of Health (DAL) the Albany College of Pharmacy (RH), and The University of Glasgow (IBM), Albany, New York, USA PubMed articlesGoogle scholar articles
  • Robert Hamilton Division of Rheumatology, Department of Medicine, Albany Medical College, and The Center for Rheumatology (JMK), The New York State Department of Health (DAL) the Albany College of Pharmacy (RH), and The University of Glasgow (IBM), Albany, New York, USA PubMed articlesGoogle scholar articles
  • Iain B McInnes Division of Rheumatology, Department of Medicine, Albany Medical College, and The Center for Rheumatology (JMK), The New York State Department of Health (DAL) the Albany College of Pharmacy (RH), and The University of Glasgow (IBM), Albany, New York, USA PubMed articlesGoogle scholar articles

Citation

Kremer JM, Lawrence DA, Hamilton R, et al
Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures
RMD Open 2016;2:e000287. doi: 10.1136/rmdopen-2016-000287

Publication history

  • Received March 29, 2016
  • Revision received May 3, 2016
  • Accepted May 13, 2016
  • First published June 9, 2016.
Online issue publication 
July 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/